Causaly

Causaly is an agentic AI research platform for life sciences R&D, founded in London in 2018 and used by pharmaceutical and biotech teams for target identification, drug repositioning, mechanism-of-action work, safety assessment, biomarker research and competitive intelligence. Named clients include Novo Nordisk, Teva, UCB, Eisai, Ipsen, Lupin, Kyowa Kirin, ProQR, Scripps Research and Innate Pharma. Answers are grounded in Causaly's own biomedical knowledge graphs rather than in a general-purpose model alone. Bio Graph maps how genes, proteins, diseases and drugs relate across more than 500 million facts, and Pipeline Graph connects that biology to the global drug development pipeline, adding more than four million data points a month at its June 2025 launch. A retrieval layer combines semantic search with graph-based ranking, and every claim carries a citation that opens to the highlighted source passage. Agentic Research plans and runs multi-step investigations across this evidence, and Scientific Workflows, introduced on May 28, 2026, makes expert research methods repeatable automations for whole R&D teams. Causaly now sells two ways. Causaly Research is self-serve: Pro costs $99 per month for one user with 400 credits and includes fast and extended reasoning, a live corpus of more than 40 million biomedical documents, an MCP connector library, code execution, chemical-structure search, evidence alerts and PDF and PowerPoint exports. Intelligence costs $149 per month with 500 credits and adds the Bio Graph and Pipeline Graph agents and full text from Sage and Mary Ann Liebert journals. A Team plan at $250 per seat per month for 3 to 15 seats is listed as coming in October 2026. The live plans start with a 14-day trial and no credit card, and prices exclude sales tax or VAT. Enterprise deployments, which add the Enterprise Data Fabric for internal data, are priced through sales. Every plan reads from PubMed and MEDLINE abstracts, PubMed Central full text, bioRxiv and medRxiv preprints, more than 550,000 clinical trials, 1.6 million patents, the GWAS Catalog, FDA labels, news and live web search. Since September 17, 2026, enterprise customers can also use Causaly inside Microsoft 365 Copilot and Microsoft Teams. Enterprise teams can bring internal data in through connectors to Microsoft Azure, Google Cloud and AWS, and the Bio Graph API gives bioinformaticians programmatic access to the knowledge graph. On MCP, Causaly connects out to external tools through its connector library today, and the Team plan lists both connecting your own MCP servers and accessing Causaly via MCP as coming features. Causaly announced ISO 27001 certification in 2022, and its trust center is available on request. Its business terms for Causaly Research state that Causaly will not use Customer Content to train, fine-tune or otherwise develop AI or machine-learning models. Feedback, personalization and system data and customer queries may be used to develop, improve and support the software, and the commitment not to train on that performance data applies to Team plan customers. Published outcomes come from attributed case studies: ProQR reported 5x productivity over PubMed for target identification in February 2025, and a top-10 global life sciences company cut proposal time by 75% during a disease area transition in April 2026. Causaly is built for biomedical evidence specifically, and the catalog carries options for broader academic work: Elicit focuses on systematic reviews and research reports across published papers and clinical trials, Consensus is an academic search engine over peer-reviewed papers, Scite.ai shows whether later papers support or contrast a finding, and ChatGPT Deep Research writes cited reports from the web, files and connected apps. Current state Q4 2026: Causaly Research is open to individual researchers and small teams on self-serve plans from $99 per month with a 14-day trial, alongside enterprise contracts through sales. Causaly became available inside Microsoft 365 Copilot and Teams in September 2026, and a Team plan with MCP access is listed for October 2026.